Claims for Patent: 7,428,875

Summary for Patent: 7,428,875

Title:	Traceability of transgenic plant seeds in upstream and downstream processing
Abstract:	The present invention relates to improved methods for increasing containment and traceability of transgenic seeds, both prior to harvest and post harvest. Disclosed are methods to produce and select a desirable plant cultivar for molecular farming characterized by being easily amenable for transformation and regeneration and with visual characteristic feature such as in particular characteristic pigmentation of the seed coat or other parts of the seed that can be traced and are easily distinguished in the field or during and/or after harvesting from non-transgenic seeds of the same species that have not the visual characteristic feature.
Inventor(s):	Orvar; Bjorn Larus (Kopavogur, IS)
Assignee:	ORF Liftaekni EHF. (Reykjavik, IS)
Application Number:	11/659,690
Patent Claims:	1. A process for producing a transformable plant for use in molecular farming with traceable seeds having a visual characteristic feature, comprising the steps of: (a) providing a desirable first cultivar for expression and accumulation of a heterologous protein in its seeds or any part thereof, wherein said cultivar is amenable for plant transformation and plant regeneration through tissue culture, and (b) providing a second cultivar with seeds that have a visual characteristic feature such that seeds of said cultivar are visually substantially different from the seeds of common agricultural or wild cultivars of the same species that grow in the geographic region intended for growing said transformed plant, (c) crossing said second cultivar with said first cultivar to yield a hybrid line, (d) back-crossing said hybrid line with said first cultivar to obtain hybrid plants, the genome of which are substantially comprised of the genome of said first cultivar, and have seeds with the same visual characteristic feature as seeds in said second cultivar, (e) selecting from said hybrid plants a host hybrid line which retains the characteristics of said first cultivar making it amenable for plant transformation and plant regeneration. 2. The process of claim 1 wherein said visual characteristic feature is a substantially different seed colour than the seed colour of said common agricultural or wild cultivars of the same species that grow in the geographic region intended for growing said transformed plant. 3. The process of claim 2 wherein at least 50% of the surface of said visibly labelled seeds of said genetically transformed plant have substantially different colour from the seed colour of common agricultural or wild cultivars of the same species that grow in the geographic region intended for growing said transformed plant. 4. The process of claim 1 wherein said genetically transformed plant is a monocotyledonous plant. 5. The process of claim 4 wherein said genetically transformed plant is barley. 6. The process of claim 1 wherein the back-crossing step (d) is repeated at least once to obtain said hybrid plants. 7. The process of claim 6, wherein the back-crossing step (d) is repeated at least twice to obtain said hybrid plants. 8. The process of claim 1, wherein microspores from the said hybrid plants are used for tissue culture to yield isogenic hybrid lines amenable for plant transformation and plant regeneration with seeds having said different colour. 9. The process of claim 8, wherein a plurality of said isogenic hybrid plants are transformed with a nucleic acid construct comprising a selectable marker gene operably linked to a promoter, and wherein said host hybrid line is selected based on evaluating the efficiency of transformation and expression of a gene product of said nucleic acid construct. 10. The process of claim 1, further comprising the steps of: (f) providing a nucleic acid construct that comprises a nucleic acid sequence encoding a plant-active promoter operably linked to a nucleotide sequence encoding a heterologous protein of interest, (g) transfonning one or more cells from said host hybrid line with said nucleic acid construct, (h) regenerating a plant from said transformed one or more plant host cells from said host hybrid line, and growing said plant to obtain a genetically transformed plant with visibly labeled seeds expressing said heterologous protein. 11. The process of claim 10 wherein said promoter is a seed-specific promoter. 12. The process of claim 10 wherein said heterologous protein of interest is selected from the group consisting of collagens, collagenase, homeobox polypeptides, monoclonal antibodies, secreted antibodies, antibody singe chains including light chains and heavy chains, manno se-binding lectin, pepsin, chymotrypsin, trypsin, casein, human growth hormone, human serum albumin, human insulin, cellulases, pectinases, hemicellulases, phytases, hydrolases, peroxidases, fibrinogen, factor LX, factor XIII, thrombin, protein C, xylanase, isoamylase, glucoamylase, amylases, lysozyme, beta.-glucanase, glucocerebrosidase, caseins, lactase, urease, glucose isomerase, invertase, streptavidin, esterases, alkaline phosphatase, protease inhibitors, pepsin, chymotrypsin, trypsin, papain, kinases, phosphatases, deoxyribonucleases, ribonucleases, phosphlipases, lipases, laccase, spider silk proteins, antifreeze proteins, antimicrobial peptides or defensins, growth factors and cytokinins. 13. The process of claim 10 wherein said heterologous protein of interest is leukemia inhibitory factor. 14. The process of claim 10 wherein said nucleic acid construct comprises a nucleic acid sequence encoding a cellulose binding module (cbm) adjacent to the nucleic acid sequence encoding said heterdogous protein of interest, optionally intercepted by a nucleic acid sequence encoding a proteolytic cleavage site. 15. The process of claim 10 wherein said genetically transformed plant with said visibly labelled seeds is grown under conditions whereby said nucleic acid sequence encoding said heteroingus protein of interest is expressed such that said protein is accumulated in the seeds of said plant. 16. A transgenic barley plant expressing in its seeds a heterologous protein of interest, producing in its seeds or seed coat a pigment that is substantially visibly different from the natural yellow seed colour of conventional barley such as the barley species Hordeum vulgaris which is produced by the process of claim 10. 17. The process of claim 1, wherein said plant is transformable with agrobacterium. 18. A transgenic barley plant expressing in its seeds a heterologous protein of interest, producing in its seeds or seed coat a pigment that is substantially visibly different from the natural yellow seed colour of conventional barley such as the barley species Hordeum vulgaris. 19. The transgenic barley plant of claim 18 producing black, red or blue pigment sufficient to give the seeds of the plant a noticeable blue, red, grey or black color. 20. The transgenic barley plant of claim 18 expressing substantially all of said heterologous protein in its seeds. 21. The transgenic barley plant of claim 18 having in its genome a seed-specific promoter operably linked to the nucleic acid sequence encoding said heterologous protein. 22. The transgenic barley plant of claim 21 wherein said seed-specific promoter is selected from the group consisting of promoters from monocotyledonous plant that are primarily seed-specific. 23. The transgenic barley plant of claim 18, which plant is isogenic. 24. The transgenic barley plant of claim 18 being amenable to tissue culture and genetic transformation. 25. The transgenic barley plant of claim 18, wherein said heterologous protein is expressed as a fusion protein comprising a carbohydrate binding module. 26. A process for producing a heterologous protein of interest comprising: (a) growing a tranagenic barley plant according to claim 18, which plant has visibly different seeds from common agricultural or wild cultivars of the same species that grow in the geographic region said transgenic barley plant expressing in its seeds said heterologous protein of interest, (b) harvesting said plant and (c) extracting from its seeds said heterologous protein. 27. The process of claim 26 wherein a plurality of said transgenic barley plants are grown in an outdoor field, separated from any non-transgenic barley plants.

Details for Patent 7,428,875

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942		2024-08-11
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954		2024-08-11
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2024-08-11